Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): di...
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
About this item
Full title
Author / Creator
EORTC Melanoma Group , Eggermont, Alexander M M, MD , Blank, Christian U, MD , Mandalà, Mario, MD , Long, Georgina V, Prof , Atkinson, Victoria G, MD , Dalle, Stéphane, Prof , Haydon, Andrew M, MD , Meshcheryakov, Andrey, Prof , Khattak, Adnan, MD , Carlino, Matteo S, BMedSc , Sandhu, Shahneen, Prof , Larkin, James, Prof , Puig, Susana, MD , Ascierto, Paolo A, Prof , Rutkowski, Piotr, Prof , Schadendorf, Dirk, Prof , Koornstra, Rutger, MD , Hernandez-Aya, Leonel, MD , Di Giacomo, Anna Maria, Prof , van den Eertwegh, Alfonsus J M, Prof , Grob, Jean-Jacques, Prof , Gutzmer, Ralf, Prof , Jamal, Rahima, MD , Lorigan, Paul C, Prof , van Akkooi, Alexander C J, MD , Krepler, Clemens, MD , Ibrahim, Nageatte, MD , Marreaud, Sandrine, MD , Kicinski, Michal, PhD , Suciu, Stefan, PhD and Robert, Caroline, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundThe European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 trial assessed pembrolizumab versus placebo in patients with resected high-risk stage III melanoma. At 15-month median follow-up, pembrolizumab improved recurrence-free survival (hazard ratio [HR] 0·57 [98·4% CI 0·43–0·74], p<0·0001) compared wi...
Alternative Titles
Full title
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Eggermont, Alexander M M, MD
Blank, Christian U, MD
Mandalà, Mario, MD
Long, Georgina V, Prof
Atkinson, Victoria G, MD
Dalle, Stéphane, Prof
Haydon, Andrew M, MD
Meshcheryakov, Andrey, Prof
Khattak, Adnan, MD
Carlino, Matteo S, BMedSc
Sandhu, Shahneen, Prof
Larkin, James, Prof
Puig, Susana, MD
Ascierto, Paolo A, Prof
Rutkowski, Piotr, Prof
Schadendorf, Dirk, Prof
Koornstra, Rutger, MD
Hernandez-Aya, Leonel, MD
Di Giacomo, Anna Maria, Prof
van den Eertwegh, Alfonsus J M, Prof
Grob, Jean-Jacques, Prof
Gutzmer, Ralf, Prof
Jamal, Rahima, MD
Lorigan, Paul C, Prof
van Akkooi, Alexander C J, MD
Krepler, Clemens, MD
Ibrahim, Nageatte, MD
Marreaud, Sandrine, MD
Kicinski, Michal, PhD
Suciu, Stefan, PhD
Robert, Caroline, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03670721v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03670721v1
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(21)00065-6
